<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39340009</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-393X</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>28</Day></PubDate></JournalIssue><Title>Vaccines</Title><ISOAbbreviation>Vaccines (Basel)</ISOAbbreviation></Journal><ArticleTitle>Immunogenicity and Protective Efficacy of Baculovirus-Expressed SARS-CoV-2 Envelope Protein in Mice as a Universal Vaccine Candidate.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">977</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/vaccines12090977</ELocationID><Abstract><AbstractText>The envelope (env) protein of SARS-CoV-2, a pivotal component of the viral architecture, plays a multifaceted role in viral assembly, replication, pathogenesis, and ion channel activity. These features make it a significant target for understanding virus-host interactions and developing vaccines to combat COVID-19. Recent structural studies provide valuable insights into the conformational dynamics and membrane topology of the SARS-CoV-2 env protein, shedding light on its functional mechanisms. The strong homology and highly conserved structure of the SARS-CoV-2 env protein shape its immunogenicity and functional characteristics. This study examines the ability of the recombinant SARS-CoV-2 env protein to stimulate an immune response. In this study, recombinant envelope proteins were produced using the baculovirus expression system, and their potential efficacy was evaluated in both in vivo and in vitro models. Our results reveal that the env protein of SARS-CoV-2 stimulates humoral and cellular responses and highlight its potential as a promising vaccine candidate for combating the ongoing pandemic.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Oğuzoğlu</LastName><ForeName>Tuba Çiğdem</ForeName><Initials>TÇ</Initials><Identifier Source="ORCID">0000-0003-4021-2414</Identifier><AffiliationInfo><Affiliation>Department of Virology, Faculty of Veterinary Medicine, Ankara University, Ankara 06070, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hanifehnezhad</LastName><ForeName>Alireza</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Virology, Faculty of Veterinary Medicine, Ankara University, Ankara 06070, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khabbazi</LastName><ForeName>Saber Delpasand</ForeName><Initials>SD</Initials><Identifier Source="ORCID">0000-0002-1697-9327</Identifier><AffiliationInfo><Affiliation>Department of Agriculture and Food, Institute of Hemp Research, Yozgat Bozok University, Yozgat 66900, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karayel-Hacıoğlu</LastName><ForeName>İlke</ForeName><Initials>İ</Initials><Identifier Source="ORCID">0000-0003-1566-630X</Identifier><AffiliationInfo><Affiliation>Department of Virology, Faculty of Veterinary Medicine, Ankara University, Ankara 06070, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaynarcalıdan</LastName><ForeName>Onur</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0003-0035-1540</Identifier><AffiliationInfo><Affiliation>Institute for Virology, Düsseldorf University Hospital, Heinrich-Heine-University, 40225 Düsseldorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fırat</LastName><ForeName>Zehra</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0003-3014-0939</Identifier><AffiliationInfo><Affiliation>Biotechnology Institute, Ankara University, Ankara 06560, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Filazi</LastName><ForeName>Nazlıcan</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0003-4424-6910</Identifier><AffiliationInfo><Affiliation>Graduate School of Health Sciences, Ankara University, Ankara 06560, Türkiye.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Virology, Faculty of Veterinary Medicine, Hatay Mustafa Kemal University, Hatay 31040, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Erdem-Şahinkesen</LastName><ForeName>Eda</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-8116-0721</Identifier><AffiliationInfo><Affiliation>Graduate School of Health Sciences, Ankara University, Ankara 06560, Türkiye.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Vaccine Technology, Vaccine Institute, Hacettepe University, Ankara 06100, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gül</LastName><ForeName>Buket</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0001-6584-8916</Identifier><AffiliationInfo><Affiliation>Graduate School of Health Sciences, Ankara University, Ankara 06560, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karabulut</LastName><ForeName>Muhammed Cesim</ForeName><Initials>MC</Initials><Identifier Source="ORCID">0009-0003-2231-4174</Identifier><AffiliationInfo><Affiliation>Department of Virology, Faculty of Veterinary Medicine, Ankara University, Ankara 06070, Türkiye.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate School of Health Sciences, Ankara University, Ankara 06560, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koba</LastName><ForeName>Enes</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Graduate School of Health Sciences, Ankara University, Ankara 06560, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adıgüzel</LastName><ForeName>Ece</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Republic of Türkiye Ministry of Agriculture and Forestry, Atkaracalar District Directorate, Çankırı 18310, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Şenlik</LastName><ForeName>Elif İrem</ForeName><Initials>Eİ</Initials><Identifier Source="ORCID">0009-0001-9603-2044</Identifier><AffiliationInfo><Affiliation>Graduate School of Health Sciences, Ankara University, Ankara 06560, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Korkulu</LastName><ForeName>Emrah</ForeName><Initials>E</Initials><Identifier Source="ORCID">0009-0009-1115-2687</Identifier><AffiliationInfo><Affiliation>Graduate School of Health Sciences, Ankara University, Ankara 06560, Türkiye.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Virology, Faculty of Veterinary Medicine, Kafkas University, Kars 36000, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Demirden</LastName><ForeName>Cansu</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Graduate School of Health Sciences, Ankara University, Ankara 06560, Türkiye.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Republic of Türkiye Ministry of Agriculture and Forestry, East Anatolian Agricultural Research Institute, Erzurum 25090, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Şahinkesen</LastName><ForeName>İlker</ForeName><Initials>İ</Initials><Identifier Source="ORCID">0000-0002-1915-6908</Identifier><AffiliationInfo><Affiliation>Diagen Biotechnological Systems Health Services and Automation Industry, Ankara 06070, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ceylan</LastName><ForeName>Ahmet</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Histology and Embryology, Faculty of Veterinary Medicine, Ankara University, Ankara 06070, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muratoğlu</LastName><ForeName>Hacer</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-8973-6449</Identifier><AffiliationInfo><Affiliation>Department of Molecular Biology and Genetics, Faculty of Sciences, Karadeniz Technical University, Trabzon 61080, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vural</LastName><ForeName>Sevil</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pathology, Faculty of Veterinary Medicine, Ankara University, Ankara 06070, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Demirbağ</LastName><ForeName>Zihni</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Biology, Faculty of Sciences, Karadeniz Technical University, Trabzon 61080, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Özkul</LastName><ForeName>Aykut</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-5008-9443</Identifier><AffiliationInfo><Affiliation>Department of Virology, Faculty of Veterinary Medicine, Ankara University, Ankara 06070, Türkiye.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>120O563</GrantID><Agency>Scientific and Technological Research Council of Turkey</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Vaccines (Basel)</MedlineTA><NlmUniqueID>101629355</NlmUniqueID><ISSNLinking>2076-393X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">baculovirus</Keyword><Keyword MajorTopicYN="N">envelope protein</Keyword><Keyword MajorTopicYN="N">recombinant</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39340009</ArticleId><ArticleId IdType="pmc">PMC11435448</ArticleId><ArticleId IdType="doi">10.3390/vaccines12090977</ArticleId><ArticleId IdType="pii">vaccines12090977</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Masters P.S. The Molecular Biology of Coronaviruses. Adv Virus Res. 2006;66:193–292. doi: 10.1016/S0065-3527(06)66005-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0065-3527(06)66005-3</ArticleId><ArticleId IdType="pmc">PMC7112330</ArticleId><ArticleId IdType="pubmed">16877062</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed S.F., Quadeer A.A., McKay M.R. Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies. Viruses. 2020;12:254. doi: 10.3390/v12030254.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12030254</ArticleId><ArticleId IdType="pmc">PMC7150947</ArticleId><ArticleId IdType="pubmed">32106567</ArticleId></ArticleIdList></Reference><Reference><Citation>Severance E.G., Bossis I., Dickerson F.B., Stallings C.R., Origoni A.E., Sullens A., Yolken R.H., Viscidi R.P. Development of a Nucleocapsid-Based Human Coronavirus Immunoassay and Estimates of Individuals Exposed to Coronavirus in a U.S. Metropolitan Population. Clin. Vaccine Immunol. 2008;15:1805–1810. doi: 10.1128/CVI.00124-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CVI.00124-08</ArticleId><ArticleId IdType="pmc">PMC2593164</ArticleId><ArticleId IdType="pubmed">18945884</ArticleId></ArticleIdList></Reference><Reference><Citation>Korber B., Fischer W.M., Gnanakaran S., Yoon H., Theiler J., Abfalterer W., Hengartner N., Giorgi E.E., Bhattacharya T., Foley B., et al. Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus. Cell. 2020;182:812–827.e19. doi: 10.1016/j.cell.2020.06.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.06.043</ArticleId><ArticleId IdType="pmc">PMC7332439</ArticleId><ArticleId IdType="pubmed">32697968</ArticleId></ArticleIdList></Reference><Reference><Citation>Khare S., Gurry C., Freitas L., Schultz M.B., Bach G., Diallo A., Akite N., Ho J., Raphael Tc Lee R., Yeo W., et al. GISAID’s Role in Pandemic Response. China CDC Wkly. 2021;3:1049–1051. doi: 10.46234/ccdcw2021.255.</Citation><ArticleIdList><ArticleId IdType="doi">10.46234/ccdcw2021.255</ArticleId><ArticleId IdType="pmc">PMC8668406</ArticleId><ArticleId IdType="pubmed">34934514</ArticleId></ArticleIdList></Reference><Reference><Citation>Abavisani M., Rahimian K., Kodori M., Khayami R., Mollapour Sisakht M., Mahmanzar M., Meshkat Z. In silico analysis of the substitution mutations and evolutionary trends of the SARS-CoV-2 structural proteins in Asia. Iran. J. Basic Med. Sci. 2022;25:1299–1307. doi: 10.22038/IJBMS.2022.66649.14620.</Citation><ArticleIdList><ArticleId IdType="doi">10.22038/IJBMS.2022.66649.14620</ArticleId><ArticleId IdType="pmc">PMC9699957</ArticleId><ArticleId IdType="pubmed">36474565</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbasian M.H., Mahmanzar M., Rahimian K., Mandavi B., Tokhanbigli S., Moradi B., Sisakht M.M., Deng Y. Global landscape of SARS-CoV-2 mutations and conserved regions. J. Transl. Med. 2023;21:152. doi: 10.1186/s12967-023-03996-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-023-03996-w</ArticleId><ArticleId IdType="pmc">PMC9958328</ArticleId><ArticleId IdType="pubmed">36841805</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos-Mendoza T. The Envelope (E) Protein of SARS-CoV-2 as a Pharmacological Target. Viruses. 2023;15:1000. doi: 10.3390/v15041000.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15041000</ArticleId><ArticleId IdType="pmc">PMC10143767</ArticleId><ArticleId IdType="pubmed">37112980</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun S., Karki C., Aguilera J., Lopez Hernandez A.E., Sun J., Li L. Computational Study on the Function of Palmitoylation on the Envelope Protein in SARS-CoV-2. J. Chem. Theory Comput. 2021;17:6483–6490. doi: 10.1021/acs.jctc.1c00359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jctc.1c00359</ArticleId><ArticleId IdType="pmc">PMC8457325</ArticleId><ArticleId IdType="pubmed">34516136</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Y., Yang R., Lee I., Zhang W., Sun J., Wang W., Meng X. Characterization of the SARS-CoV-2 E Protein: Sequence, Structure, Viroporin, and Inhibitors. Protein Sci. 2021;30:1114–1130. doi: 10.1002/pro.4075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.4075</ArticleId><ArticleId IdType="pmc">PMC8138525</ArticleId><ArticleId IdType="pubmed">33813796</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanifehnezhad A., Kehribar E.Ş., Öztop S., Sheraz A., Kasırga S., Ergünay K., Önder S., Yılmaz E., Engin D., Oğuzoğlu T.Ç., et al. Characterization of Local SARS-CoV-2 Isolates and Pathogenicity in IFNAR−/- Mice. Heliyon. 2020;6:e05116. doi: 10.1016/j.heliyon.2020.e05116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2020.e05116</ArticleId><ArticleId IdType="pmc">PMC7522675</ArticleId><ArticleId IdType="pubmed">33015402</ArticleId></ArticleIdList></Reference><Reference><Citation>Spearman C. The Method of “Right and Wrong Cases” (Constant Stimuli) without Gauss’s Formula. Br. J. Psychol. 1908;2:227–242. doi: 10.1111/j.2044-8295.1908.tb00176.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.2044-8295.1908.tb00176.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Kärber G. Beitrag Zur Kollektiven Behandlung Pharmakologischer Reihenversuche. Naunyn-Schmiedebergs Arch. Für Exp. Pathol. Und Pharmakol. 1931;162:480–483. doi: 10.1007/BF01863914.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01863914</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradford M. A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding. Anal. Biochem. 1976;72:248–254. doi: 10.1016/0003-2697(76)90527-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0003-2697(76)90527-3</ArticleId><ArticleId IdType="pubmed">942051</ArticleId></ArticleIdList></Reference><Reference><Citation>Clements C.J., Griffiths E. The Global Impact of Vaccines Containing Aluminium Adjuvants. Vaccine. 2002;20:S24–S33. doi: 10.1016/S0264-410X(02)00168-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0264-410X(02)00168-8</ArticleId><ArticleId IdType="pubmed">12184361</ArticleId></ArticleIdList></Reference><Reference><Citation>Bode C., Zhao G., Steinhagen F., Kinjo T., Klinman D.M. CpG DNA as a Vaccine Adjuvant. Expert Rev. Vaccines. 2011;10:499–511. doi: 10.1586/erv.10.174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/erv.10.174</ArticleId><ArticleId IdType="pmc">PMC3108434</ArticleId><ArticleId IdType="pubmed">21506647</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang Z., Zhu H., Wang X., Jing B., Li Z., Xia X., Sun H., Yang Y., Zhang W., Shi L., et al. Adjuvants for Coronavirus Vaccines. Front. Immunol. 2020;11:589833. doi: 10.3389/fimmu.2020.589833.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.589833</ArticleId><ArticleId IdType="pmc">PMC7677582</ArticleId><ArticleId IdType="pubmed">33240278</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharya S., Banerjee A., Ray S. Development of New Vaccine Target against SARS-CoV2 Using Envelope (E) Protein: An Evolutionary, Molecular Modeling and Docking Based Study. Int. J. Biol. Macromol. 2021;172:74–81. doi: 10.1016/j.ijbiomac.2020.12.192.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2020.12.192</ArticleId><ArticleId IdType="pmc">PMC7833863</ArticleId><ArticleId IdType="pubmed">33385461</ArticleId></ArticleIdList></Reference><Reference><Citation>Ono C., Okamoto T., Abe T., Matsuura Y. Baculovirus as a Tool for Gene Delivery and Gene Therapy. Viruses. 2018;10:510. doi: 10.3390/v10090510.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v10090510</ArticleId><ArticleId IdType="pmc">PMC6164903</ArticleId><ArticleId IdType="pubmed">30235841</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchholz U.J., Bukreyev A., Yang L., Lamirande E.W., Murphy B.R., Subbarao K., Collins P.L. Contributions of the Structural Proteins of Severe Acute Respiratory Syndrome Coronavirus to Protective Immunity. Proc. Natl. Acad. Sci. USA. 2004;101:9804–9809. doi: 10.1073/pnas.0403492101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0403492101</ArticleId><ArticleId IdType="pmc">PMC470755</ArticleId><ArticleId IdType="pubmed">15210961</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Zhao X., Zhou H., Zhu H., Jiang S., Wang P. Broadly Neutralizing Antibodies to SARS-CoV-2 and Other Human Coronaviruses. Nat. Rev. Immunol. 2023;23:189–199. doi: 10.1038/s41577-022-00784-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-022-00784-3</ArticleId><ArticleId IdType="pmc">PMC9514166</ArticleId><ArticleId IdType="pubmed">36168054</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M.Y., Zhao R., Gao L.J., Gao X.F., Wang D.P., Cao J.M. SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development. Front. Cell. Infect. Microbiol. 2020;10:587269. doi: 10.3389/fcimb.2020.587269.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2020.587269</ArticleId><ArticleId IdType="pmc">PMC7723891</ArticleId><ArticleId IdType="pubmed">33324574</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai C. Universal COVID-19 Vaccine Targeting SARS-CoV-2 Envelope Protein. World J. Vaccines. 2021;11:19–27. doi: 10.4236/wjv.2021.113003.</Citation><ArticleIdList><ArticleId IdType="doi">10.4236/wjv.2021.113003</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghafouri F., Cohan R.A., Noorbakhsh F., Samimi H., Haghpanah V. An in-silico approach to develop of a multi-epitope vaccine candidate against SARS-CoV-2 envelope (E) protein. Res. Sq. 2020:preprint. doi: 10.21203/rs.3.rs-30374/v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-30374/v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan L., Liu P., Li X., Zhou S., Li H., Wang Z., Shen F., Lu B., Long Y., Xiao X., et al. Neutralizing Antibodies and Cellular Immune Responses Against SARS-CoV-2 Sustained One and a Half Years After Natural Infection. Front. Microbiol. 2022;12:803031. doi: 10.3389/fmicb.2021.803031.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.803031</ArticleId><ArticleId IdType="pmc">PMC8928406</ArticleId><ArticleId IdType="pubmed">35310397</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoenborn J.R., Wilson C.B. Regulation of Interferon-γ During Innate and Adaptive Immune Responses. Adv. Immunol. 2007;90:41–101.</Citation><ArticleIdList><ArticleId IdType="pubmed">17981204</ArticleId></ArticleIdList></Reference><Reference><Citation>Josephs S.F., Ichim T.E., Prince S.M., Kesari S., Marincola F.M., Escobedo A.R., Jafri A. Unleashing Endogenous TNF-Alpha as a Cancer Immunotherapeutic. J. Transl. Med. 2018;16:242. doi: 10.1186/s12967-018-1611-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-018-1611-7</ArticleId><ArticleId IdType="pmc">PMC6119315</ArticleId><ArticleId IdType="pubmed">30170620</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang E.S., Hong J.-H., Glimcher L.H. IL-2 Production in Developing Th1 Cells Is Regulated by Heterodimerization of RelA and T-Bet and Requires T-Bet Serine Residue 508. J. Exp. Med. 2005;202:1289–1300. doi: 10.1084/jem.20051044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20051044</ArticleId><ArticleId IdType="pmc">PMC2213245</ArticleId><ArticleId IdType="pubmed">16275766</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao W., Lin J.-X., Leonard W.J. IL-2 Family Cytokines: New Insights into the Complex Roles of IL-2 as a Broad Regulator of T Helper Cell Differentiation. Curr. Opin. Immunol. 2011;23:598–604. doi: 10.1016/j.coi.2011.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2011.08.003</ArticleId><ArticleId IdType="pmc">PMC3405730</ArticleId><ArticleId IdType="pubmed">21889323</ArticleId></ArticleIdList></Reference><Reference><Citation>Gadani S.P., Cronk J.C., Norris G.T., Kipnis J. IL-4 in the Brain: A Cytokine to Remember. J. Immunol. 2012;189:4213–4219. doi: 10.4049/jimmunol.1202246.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1202246</ArticleId><ArticleId IdType="pmc">PMC3481177</ArticleId><ArticleId IdType="pubmed">23087426</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang Y., Bai M., You Q. Associations between Serum Interleukins (IL-1β, IL-2, IL-4, IL-6, IL-8, and IL-10) and Disease Severity of COVID-19: A Systematic Review and Meta-Analysis. Biomed. Res. Int. 2022;2022:2755246. doi: 10.1155/2022/2755246.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/2755246</ArticleId><ArticleId IdType="pmc">PMC9079324</ArticleId><ArticleId IdType="pubmed">35540724</ArticleId></ArticleIdList></Reference><Reference><Citation>Pala D., Pistis M. Anti-IL5 Drugs in COVID-19 Patients: Role of Eosinophils in SARS-CoV-2-Induced Immunopathology. Front. Pharmacol. 2021;12:622554. doi: 10.3389/fphar.2021.622554.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.622554</ArticleId><ArticleId IdType="pmc">PMC7985166</ArticleId><ArticleId IdType="pubmed">33767626</ArticleId></ArticleIdList></Reference><Reference><Citation>Gubernatorova E.O., Gorshkova E.A., Namakanova O.A., Zvartsev R.V., Hidalgo J., Drutskaya M.S., Tumanov A.V., Nedospasov S.A. Non-Redundant Functions of IL-6 Produced by Macrophages and Dendritic Cells in Allergic Airway Inflammation. Front. Immunol. 2018;9:2718. doi: 10.3389/fimmu.2018.02718.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02718</ArticleId><ArticleId IdType="pmc">PMC6276801</ArticleId><ArticleId IdType="pubmed">30534125</ArticleId></ArticleIdList></Reference><Reference><Citation>Heo J.Y., Seo Y.B., Kim E.J., Lee J., Kim Y.R., Yoon J.G., Noh J.Y., Cheong H.J., Kim W.J., Yoon S.-Y., et al. COVID-19 Vaccine Type-Dependent Differences in Immunogenicity and Inflammatory Response: BNT162b2 and ChAdOx1 NCoV-19. Front. Immunol. 2022;13:975363. doi: 10.3389/fimmu.2022.975363.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.975363</ArticleId><ArticleId IdType="pmc">PMC9480614</ArticleId><ArticleId IdType="pubmed">36119092</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore K.W., de Waal Malefyt R., Coffman R.L., O’Garra A. Interleukin-10 and the Interleukin-10 Receptor. Annu. Rev. Immunol. 2001;19:683–765. doi: 10.1146/annurev.immunol.19.1.683.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.immunol.19.1.683</ArticleId><ArticleId IdType="pubmed">11244051</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun K., Torres L., Metzger D.W. A Detrimental Effect of Interleukin-10 on Protective Pulmonary Humoral Immunity during Primary Influenza A Virus Infection. J. Virol. 2010;84:5007–5014. doi: 10.1128/JVI.02408-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02408-09</ArticleId><ArticleId IdType="pmc">PMC2863832</ArticleId><ArticleId IdType="pubmed">20200252</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam H., Chamberlain T.C., Mui A.L., Little J.P. Elevated Interleukin-10 Levels in COVID-19: Potentiation of Pro-Inflammatory Responses or Impaired Anti-Inflammatory Action? Front. Immunol. 2021;12:677008. doi: 10.3389/fimmu.2021.677008.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.677008</ArticleId><ArticleId IdType="pmc">PMC8255680</ArticleId><ArticleId IdType="pubmed">34234779</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindner H.A., Velásquez S.Y., Thiel M., Kirschning T. Lung Protection vs. Infection Resolution: Interleukin 10 Suspected of Double-Dealing in COVID-19. Front. Immunol. 2021;12:602130. doi: 10.3389/fimmu.2021.602130.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.602130</ArticleId><ArticleId IdType="pmc">PMC7966717</ArticleId><ArticleId IdType="pubmed">33746948</ArticleId></ArticleIdList></Reference><Reference><Citation>Rael E.L., Lockey R.F. Interleukin-13 Signaling and Its Role in Asthma. World Allergy Organ. J. 2011;4:54–64. doi: 10.1097/WOX.0b013e31821188e0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WOX.0b013e31821188e0</ArticleId><ArticleId IdType="pmc">PMC3651056</ArticleId><ArticleId IdType="pubmed">23283176</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung J.R., Kim S.S., Kondor R.J., Smith C., Budd A.P., Tartof S.Y., Florea A., Talbot H.K., Grijalva C.G., Wernli K.J., et al. Interim Estimates of 2021–22 Seasonal Influenza Vaccine Effectiveness—United States, February 2022. MMWR Morb. Mortal. Wkly. Rep. 2022;71:365–370. doi: 10.15585/mmwr.mm7110a1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7110a1</ArticleId><ArticleId IdType="pmc">PMC8911998</ArticleId><ArticleId IdType="pubmed">35271561</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>